Life of Quaid E Azam
ACCF/AHA Pocket Guideline
Adapted from the 2011 ACCF/AHA
Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
November 2011
Developed in Collaboration With the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
© 2011 by the American College of Cardiology Foundation and the American Heart Association, Inc.
The following material was adapted from the 2011 ACCF/AHA Guidelines for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy (J Am Coll Cardiol 2011;XX:XX–XX). This pocket guideline is available on the World Wide Web sites of the American College of Cardiology (www.cardiosource. org) and the American Heart Association (my.americanheart.org).
For copies of this document, please contact Elsevier Inc. Reprint Department, e-mail: reprints@elsevier.com; phone: 212-633-3813; fax: 212-633-3820.
Permissions: Multiple copies, modification, alteration, enhancement, and/ ordistribution of this document are not permitted without the express permission of the American College of Cardiology Foundation. Please contact Elsevier’s permission department at healthpermissions@elsevier.com.
Contents
1. Introduction .........................................................................................3
2. Clinical Definition ................................................................................6
3. Genetic Testing Strategies/Family Screening .....................................7
4. Genotype-Positive/Phenotype-Negative Patients .............................9
5. Echocardiography .............................................................................. 10
6. Stress Testing ..................................................................................... 14
7. Cardiac Magnetic Resonance
Adapted from the 2011 ACCF/AHA
Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
November 2011
Developed in Collaboration With the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
© 2011 by the American College of Cardiology Foundation and the American Heart Association, Inc.
The following material was adapted from the 2011 ACCF/AHA Guidelines for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy (J Am Coll Cardiol 2011;XX:XX–XX). This pocket guideline is available on the World Wide Web sites of the American College of Cardiology (www.cardiosource. org) and the American Heart Association (my.americanheart.org).
For copies of this document, please contact Elsevier Inc. Reprint Department, e-mail: reprints@elsevier.com; phone: 212-633-3813; fax: 212-633-3820.
Permissions: Multiple copies, modification, alteration, enhancement, and/ ordistribution of this document are not permitted without the express permission of the American College of Cardiology Foundation. Please contact Elsevier’s permission department at healthpermissions@elsevier.com.
Contents
1. Introduction .........................................................................................3
2. Clinical Definition ................................................................................6
3. Genetic Testing Strategies/Family Screening .....................................7
4. Genotype-Positive/Phenotype-Negative Patients .............................9
5. Echocardiography .............................................................................. 10
6. Stress Testing ..................................................................................... 14
7. Cardiac Magnetic Resonance